Key Market Indicator:
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Fri, 16.02.2024
Kion Group AG
Kion Group reported preliminary Q4 numbers that missed consensus estimates in terms of net income by 30% while adjusted EBIT at Supply Chain Solutions (SCS) fell short by 22%. Results were impacted by one-offs (including increased expenses related to completion of a client project at SCS) and higher interest expense. Encouragingly, free cash flow (FCF) surpassed the group’s 2023 guidance, and management stated that all other key line items for Q4 and full year were in line with market expectations and guidance. Overall, 2023 results have been decent, and AlsterResearch’s analysts look forward to more colour on the 2024 outlook at the time of the full release (on 29 February). AlsterResearch’s analysts reiterate their BUY recommendation at an unchanged price target of EUR 46.00. AlsterResearch’s analysts shall revisit their estimates after the full results are available. The full update can be downloaded under https://www.research-hub.de/companies/Kion%20Group%20AG
Fri, 16.02.2024
tonies SE
tonies hosted a conference call today to introduce the new CEO Tobias Wann to analysts. Tobias succeeds co-founders Patric Faßbender and Marcus Stahl, who have stepped down from their roles but will remain shareholders and advisors. With 20 years of executive experience, Tobias brings expertise in scaling platform businesses internationally, demonstrated through his previous roles at VeriSign, HomeAway, @Leisure Group, OYO and Xempus. AlsterResearch’s analysts believe his background makes him well suited to lead tonies' further growth. AlsterResearch reiterates the BUY rating on tonies with an unchanged target price of EUR 7.70. The full update can be downloaded under https://www.research-hub.de/companies/tonies%20SE
Fri, 16.02.2024
cyan AG
In light of the constant threat of cyberattacks, as demonstrated by the recent examples of Varta AG and PSI Software AG, cyan AG comes into the spotlight, announcing a 71% yoy increase of end customers in 2023. At the end of 2023, cyan sold its BSS/OSS business (i-new) to the Compax Group, an Austrian provider of business support systems (BSS) and mobile virtual network operators (MVNO) solutions. Under the leadership of the new CEO Thomas Kicker, who has extensive experience in the telecoms sector, the company is now fully focused on cybersecurity. After a 47% rise in the share price since the i-new sale, AlsterResearch still expects more upside once the market is provided with more substance on the strategy and outlook. The price target and rating remain unchanged with reference to a pending update of the model. The full update can be downloaded under https://www.research-hub.de/companies/cyan%20AG
Fri, 16.02.2024
Multitude SE
Multitude’s credit rating has been updated by the US rating agency “Fitch”. Accordingly, Fitch has upgraded the outlooks of Multitude SE and its wholly owned subsidiary Multitude Bank plc (based in Malta) from "stable" to "positive". Since 2021, Multitude has reinvented itself and this is now being recognized by Fitch. According to the rating agency, the upgrade reflects in particular the bank's improved outlook and business volumes. This is complemented by a broader diversification and improved profitability, as well as adequate capitalization supported by Multitude Bank's. In the view of AlsterResearch’s analysts, Multitude is likely to reach its FY23 targets of EUR 45m (eAR EUR 44m). This target was reaffirmed at AlsterResearch’s most recent roundtable meeting with CFO Eggert (video available: research-hub.de/events). AlsterResearch believes that Multitude is still attractively valued (P/E of only 6.0x in 24E; dividend yield of >6.0% 24E) and therefore, it remains a BUY-rating with a price target of EUR 12.60. The full update can be downloaded under https://www.research-hub.de/companies/investment-case/Multitude%20SE
Fri, 16.02.2024
R. STAHL AG
Q4 prelims: Operating turnaround intact; chg. est.
Topic: R. Stahl released solid FY23 preliminary figures, exceeding the
company’s guidance on the topline. However, Q4 profitability and order
intake were slightly weaker than expected due to a soft chemical industry
in the DACH-region.
Preliminary Q4 sales came in at € 89.9m (eNuW: [ … ]
Thu, 15.02.2024
Friedrich Vorwerk Group SE
Friedrich Vorwerk Group's (FVG) order intake was impressive last year, with an order intake of EUR 1bn after 9M alone (c. EUR 318m 9M 22), of which FVG received EUR 690m alone in Q3 23 due to the signing of the A-Nord power project (offshore grid connection system). The order backlog amounted to EUR 1.05bn at the end of Q3 23 (c. EUR 372m Q3 22). The backlog of old, poorly priced contracts is expected to be cleared in Q4 23. The EBIT margin (c. 3% FY23E; compared to 16% FY21) is expected to recover slowly in FY24 as better terms are agreed in new contracts. However the strong growth will require new hires, which will most likely lead to a slower improvement in margins initially. Nevertheless, FVG should continue to benefit from very good growth prospects driven by infrastructure renewal in Germany. Based on the strong order flow, AlsterResearch’s analysts confirm their BUY rating and their PT of EUR 21.00. https://www.research-hub.de/companies/Friedrich%20Vorwerk%20Group%20SE
Thu, 15.02.2024
Photon Energy NV
The year got off to a good start in January as Photon Energy's own photovoltaic power plant production increased by 42%, outpacing capacity growth of +39%. Against the backdrop of persistently low electricity prices, Photon Energy is returning to the feed-in tariff (FIT) in the Czech Republic and Hungary. The return to FIT in Hungary (at prices expected to be above market) de-risks over 1/3 of production capacity, which AlsterResearch’s analysts view positively in the current challenging market environment. Finally, Photon Energy has appointed David Forth as its new CFO with effect from 1 February, following the interim tenure of CEO Georg Hotar. David Forth brings with him extensive international management experience, including notable positions at BP, BAT, Schneider, Adecco, Costa Coffee and Dr Martens. AlsterResearch’s analysts reiterate their BUY recommendation with a target price of EUR 3.20. The full update can be downloaded under https://www.research-hub.de/companies/Photon%20Energy%20NV
Thu, 15.02.2024
SUESS MicroTec SE
Sam Altman, CEO of OpenAI, recently garnered attention for reportedly seeking an unprecedented investment ranging from USD 5,000 to USD 7,000 billion to address the shortage of AI-specific chips, crucial for training and running large language models like ChatGPT, Microsoft Copilot, and Google Gemini. While the scale of funding appears implausible, the shortage of AI chips is a genuine issue, driving up prices and causing project delays, with no immediate solution in sight other than expanding chip production capacity. Suess MicroTec is a key supplier of backend tools used in the production of GPUs and high-bandwidth memory, both needed in AI, which could drive growth for many years. In Q4, AlsterResearch’s analysts estimate that AI-related order intake could contribute up to 1/3 of the total, positioning Suess MicroTec as an interesting play on the AI boom. AlsterResearch’s analysts raise their estimates to reflect the accelerating momentum and arrive at a new price target of EUR 41.00 (old: EUR 32.30). The company also trades at a significant discount to slower growing peers. BUY.
Thu, 15.02.2024
Marley Spoon Group SE
Strategic transactions closed; est. & PT chg.
Marley Spoon Group ('MSG') closed the strategic transactions announced on
January 31st. Here is what you need to know:
Acquisition of BistroMD. MSG closed the acquisition of BistroMD, a leading
doctor-designed ready-toeat (RTE) meal plan company in the US (c. € 35m
revenues in 2023), offe [ … ]
Wed, 14.02.2024
CEL-SCI Corporation
First Berlin Equity Research has published a research update on CEL-SCI
Corporation (ISIN: US1508376076). Analyst Christian Orquera reiterated his
BUY rating and maintained his USD 8.40 price target.
Abstract:
CEL-SCI announced that it has completed commissioning of its US
manufacturing facility for Multikine, its lead drug candidate for advanc [ … ]